Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01975701
Title A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ESP | CHE | BEL | AUS

Facility Status City State Zip Country Details
Novartis Investigative Site Los Angeles California 90095 United States Details
University of California San Francisco Dept of Onc. San Francisco California 94101 United States Details
Novartis Investigative Site Chicago Illinois 60611 United States Details
Novartis Investigative Site Boston Massachusetts 02215 United States Details
Novartis Investigative Site New York New York 10032 United States Details
Novartis Investigative Site Columbus Ohio 43221 United States Details
Novartis Investigative Site Dallas Texas 75246 United States Details
Novartis Investigative Site Dallas Texas 75251 United States Details
Novartis Investigative Site Houston Texas 77030 United States Details
Novartis Investigative Site Melbourne Victoria 3050 Australia Details
Novartis Investigative Site Leuven 3000 Belgium Details
University Medical Center Utrecht Utrecht The Netherlands 3508 GA Netherlands Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Zürich 8091 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field